Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex
- PMID: 19211978
Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex
Abstract
The effects of repeated administration of imipramine, citalopram, tianeptine and zinc hydroaspartate, lasting 7, 14 and 21 days, were studied ex vivo in rat frontal cortical slices prepared 48 h after the last dose of the drug. In a majority of cases the treatments resulted in a decrease in the amplitude of pharmacologically isolated N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptor-mediated components of the field potential. Zinc and tianeptine-induced effects were evident already after treatments lasting 7 days. Electroconvulsive shocks applied for 10 but not for 5 days reduced both the AMPA/kainate and the NMDA receptor-mediated components. The ratios of the amplitude of NMDA to AMPA/kainate component were altered to a different degree. These results indicate that repetitive treatment with antidepressants, zinc salt and electroconvulsive shocks results in an attenuation of glutamatergic synaptic transmission in the cerebral cortex, but the dynamics of the effects of these treatments vary.
Similar articles
-
Repeated administration of antidepressants decreases field potentials in rat frontal cortex.Neuroscience. 2003;120(3):765-9. doi: 10.1016/s0306-4522(03)00380-4. Neuroscience. 2003. PMID: 12895516
-
Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex.Neuroscience. 2008 May 15;153(3):789-95. doi: 10.1016/j.neuroscience.2008.03.007. Epub 2008 Mar 8. Neuroscience. 2008. PMID: 18403127
-
Imipramine counteracts corticosterone-induced enhancement of glutamatergic transmission and impairment of long-term potentiation in the rat frontal cortex.Pharmacol Rep. 2011;63(6):1404-12. doi: 10.1016/s1734-1140(11)70704-6. Pharmacol Rep. 2011. PMID: 22358088
-
Does interaction between zinc and glutamate system play a significant role in the mechanism of antidepressant action?Acta Pol Pharm. 2001 Jan-Feb;58(1):73-5. Acta Pol Pharm. 2001. PMID: 11370292 Review.
-
Impaired glutamatergic synaptic transmission in the PKU brain.Mol Genet Metab. 2005 Dec;86 Suppl 1:S34-42. doi: 10.1016/j.ymgme.2005.06.014. Epub 2005 Sep 8. Mol Genet Metab. 2005. PMID: 16153867 Review.
Cited by
-
D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.Neuropsychopharmacology. 2014 Apr;39(5):1052-8. doi: 10.1038/npp.2013.317. Epub 2013 Nov 12. Neuropsychopharmacology. 2014. PMID: 24217129 Free PMC article. Clinical Trial.
-
Repeated administration of imipramine modifies GABAergic transmission in rat frontal cortex.J Neural Transm (Vienna). 2013 May;120(5):711-9. doi: 10.1007/s00702-012-0919-3. Epub 2012 Nov 21. J Neural Transm (Vienna). 2013. PMID: 23180303 Free PMC article.
-
Stress-induced changes of hippocampal NMDA receptors: modulation by duloxetine treatment.PLoS One. 2012;7(5):e37916. doi: 10.1371/journal.pone.0037916. Epub 2012 May 29. PLoS One. 2012. PMID: 22666412 Free PMC article.
-
Brain targeting stealth lipomers of combined antiepileptic-anti-inflammatory drugs as alternative therapy for conventional anti-Parkinson's.Saudi Pharm J. 2020 Jan;28(1):33-57. doi: 10.1016/j.jsps.2019.11.004. Epub 2019 Nov 13. Saudi Pharm J. 2020. PMID: 31920431 Free PMC article.
-
Novel glutamatergic drugs for the treatment of mood disorders.Neuropsychiatr Dis Treat. 2013;9:1101-12. doi: 10.2147/NDT.S36689. Epub 2013 Aug 7. Neuropsychiatr Dis Treat. 2013. PMID: 23976856 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical